Deafness or hearing loss is a major issue in human health. Inner ear hair cells are the main sensory receptors responsible for hearing. Defects in hair cells are one of the major causes of deafness. A combination of induced pluripotent stem cell (iPSC) technology with genome-editing technology may provide an attractive cell-based strategy to regenerate hair cells and treat hereditary deafness in humans. Here, we report the generation of iPSCs from members of a Chinese family carrying MYO15A c.4642G4A and c.8374G4A mutations and the induction of hair cell-like cells from those iPSCs. The compound heterozygous MYO15A mutations resulted in abnormal morphology and dysfunction of the derived hair cell-like cells. We used a CRISPR/Cas9 approach to genetically correct the MYO15A mutation in the iPSCs and rescued the morphology and function of the derived hair cell-like cells. Our data demonstrate the feasibility of generating inner ear hair cells from human iPSCs and the functional rescue of gene mutation-based deafness by using genetic correction. Hearing loss affects~10% of the global population, 1 and 50% of hearing loss cases have a genetic etiology.
Hearing loss affects~10% of the global population, 1 and 50% of hearing loss cases have a genetic etiology. 2 In particular, mutations in genes such as MYO15A, which are involved in the formation of inner ear sensory hair cells, account for the majority of sensorineural hearing loss cases. 3, 4 Owing to the inability to regenerate human hair cells, sensorineural hearing loss is often permanent. 5 Human and mouse embryonic stem cells (ESCs), as well as mouse induced pluripotent stem cells (iPSCs), have been used to generate cells with the characteristics of hair cells, that is, hair cell-like cells. [6] [7] [8] Mammalian inner ear sensory organs appear to be capable of incorporating transplanted cells. [9] [10] [11] [12] [13] These results suggest the potential for the development of a cellbased approach for hearing restoration.
Inner ear hair cells are largely responsible for the sense of hearing.
14 Each hair cell contains a dense actin mesh at its apical surface. This mesh is adorned with distinct hair bundles made of F-actin-filled microvilli-derived stereocilia arranged in a staircase pattern. 15 The genes that are involved in actin dynamics, including non-muscle unconventional myosin genes, have been identified as being among a limited number of key genes related to deafness.
3 MYO15A belongs to the unconventional myosin superfamily and is required for the normal development of stereocilia in hair cells. [16] [17] [18] [19] Mutations in MYO15A have been found to be associated with profound, congenital, neurosensory, nonsyndromal deafness in several Asian and European families. [20] [21] [22] [23] [24] [25] [26] [27] Since its first development by Yamanaka in 2006, iPSC technology has made rapid development in the field of regenerative medicine. [28] [29] [30] [31] CRISPR/Cas9 technology, a gene-editing technique, has offered several further potential advantages including the ease of customization, higher targeting efficiency, and the ability to facilitate multiplex genome editing. 32 Combining iPSC technology with CRISPR/Cas9 technology has gradually become an attractive strategy in the study and development of therapies for hereditary human diseases. Here, we report the generation of human iPSCs from members of a Chinese family carrying MYO15A c.4642G4A and c.8374G4A mutations. We then demonstrate the induction of iPSCs into hair cell-like cells and then apply a CRISPR/Cas9-targeting vector and two forms of homologous recombination templates to repair the MYO15A c.4642G4A mutation in the iPSCs. We found that the genetic correction rescued the abnormal phenotypes (F-actin disorganization, abnormally short stereocilia as well as syncytia formation) and dysfunction (lower current density) in the derived hair cell-like cells caused by the MYO15A mutations. Our data demonstrate the feasibility of generating inner ear hair cells from human iPSCs and the functional rescue of gene mutations causing deafness using genetic correction.
Results
Generation and characterization of iPSCs. A customized gene capture panel for 69 known deafness genes and analysis of the mitochondrial genome using next-generation sequencing (Roche NimbleGen, Inc., Madison, WI, USA) were used to identify two novel mutations in the MYO15A gene. These were c.4642G4A causing p.A1548T, and c.8374G4A causing p.V2792M and were identified in a 2-year-old male patient with profound hearing loss (III:1, Figure 1 ). Sanger sequencing of the entire MYO15A gene in the proband and in the parents showed that the proband carried the compound heterozygous MYO15A c.4642G4A and c.8374G4A mutations. The father and mother were Family members marked by a * were donors for the next-generation sequencing of deafness genes, Sanger validation, and hearing tests. The 2-year-old male child (III:1) carries two MYO15A mutations. The inheritance of the MYO15A mutations in the family indicated that the child carries compound heterozygous MYO15A mutations. (b) Sanger sequencing confirmed the MYO15A mutations identified in the family members. Double peaks represent a heterozygous mutation. (c) Audiograms of the family carrying MYO15A mutations. Audiograms of the 2-year-old male carrying the compound heterozygous MYO15A mutations (III:1), the parents each carrying a single MYO15A mutation (II:1 and II:2), and the paternal grandparents with the grandfather carrying a single MYO15A mutation (I:1 and I:2). Note that the parents and grandmother have normal hearing. The grandfather has normal hearing below 3 KHz and normal conversational hearing with peak hearing loss at frequencies between 4-6 KHz. An X represents the audition of the left ear and a circle represents the audition of right ear heterozygous for MYO15A c.8374G4A and MYO15A c.4642G4A mutations, respectively. No other mutation was found in the parents or the proband (Figure 1a and b) . Dermal fibroblasts isolated from skin punch biopsies of the proband (III:1, deaf, Figure 1c ) and the father (II:1, normal hearing, Figure 1c ) as well as a female girl (normal hearing) with no MYO15A mutation were designated as M − / − , M+/ − , and M+/+, respectively. Four key transcription factor genes OCT4, SOX2, KLF4, and c-MYC were introduced into the three fibroblast lines using a retroviral method (Supplementary Figure S1 ). Approximately 3 weeks later, human iPSC-like colonies with a high nuclear-cytoplasmic ratio were observed. Single colonies were then selected and separately subcultured (Figure 2a) .
Multiple assays were performed to fully characterize the generated putative iPSC lines. Alkaline phosphatase (AP) staining revealed that all three putative iPSC lines were positive for AP (Figure 2a ). Immunocytochemistry showed that Tissue structure characteristics of the three germ layers were observed (gut epithelium for endoderm, cartilage for mesoderm, as well as neural rosettes and retinal pigment epithelium for ectoderm). Scale: 50 μm in NANOG images; 100 μm in the other images all three putative iPSC lines expressed iPSC markers OCT4, SOX2, NANOG, SSEA4, TRA-1-60, and TRA-1-81 (Figure 2b ). Three clones from each putative iPSC line were picked out to examine the expression of iPSC-specific endogenous and exogenous transgenes. iPSC endogenous marker genes were expressed in all three putative iPSC lines, whereas most exogenous transgenes were silenced (Supplementary Figure S2a) . The karyotypes of the three putative iPSC lines were analyzed and confirmed to be normal (Supplementary Figure S2b) .
Putative iPSC clones with silenced exogenous transgenes, including Clone 3 (C3) from M +/+ , C4 from M +/ − , and C7 from M − / − (Supplementary Figure S2a) were subjected to totipotency analysis. Embryoid bodies (EBs) were formed after 8-day suspension culture of these putative iPSCs (Figure 2c ). Specific marker genes for each of the three germ layers (AFP and SOX17 for the endoderm, Brachyury and MSX1 for the mesoderm, and PAX6 and MAP2 for the ectoderm) were detected and quantified after a subsequent 8-day adherent culture (Supplementary Figures S2c and e) . In addition, teratoma formation was utilized to test the in vivo differentiation totipotency and tridermogenesis of the putative iPSC lines. Each teratoma contained tissue structures characteristic of the three germ layers. More specifically, these included tissues of the gut epithelium, cartilage, and neural rosettes and retinal pigment epithelium of endodermal mesodermal, and ectodermal origin (Figure 2d ). These results indicated that we had successfully generated three iPSC lines ( M+/+ iPSCs, M+/ − iPSCs, and M − / − iPSCs) with full characterizations.
Potentials of M+/+ iPSCs, M+/ − iPSCs, and M − / − iPSCs for differentiation into inner ear hair cells. We subsequently tested the potential of these iPSCs to differentiate into inner ear hair cells (Supplementary Figure S1) . We used the monolayer induction method to induce the differentiation of the three iPSC lines toward the otic progenitors. 8 After 12 days of induction, cells induced from all three iPSC lines expressed early otic markers, including PAX2, PAX8, SOX2, and NES (Figure 3a and c). The expression of other early otic marker genes, including GATA3, EYA1, SIX1, and DLX5, was also detected (Figure 3d ). No significant difference in otic gene expression was observed between the three otic progenitors (Figure 3e , P40.05).
The otic epithelial progenitors generated from the human iPSCs were isolated and further induced to differentiate into inner ear hair cells. 6, 8 The otic epithelial progenitors were cultured for 3 weeks on mitotically inactivated chicken embryonic utricle stromal cells (CUSCs). Immunocytochemistry and Western blot assays were then performed to examine the expression of hair cell marker proteins in the induced hair cell-like cells. The results showed that the hair cell markers, ATOH1, 33, 34 and BRN3C, 35 the early hair cell structural protein, MYO7A, 17 as well as the protein required for hair bundle development, ESPN, 36 were all expressed (Figure 4a and e). Gene expression analysis also revealed the expression of hair cell marker genes, including ATOH1, BRN3C, MYO7A, and ESPN (Figure 4f ). In addition, transcripts from MYO15A were at similar levels in the induced hair cell-like cells derived from all the three iPSC lines (Figure 4g ).
We further assessed the functional characteristics of these induced cells using FM1-43 uptake experiments 7 and electrophysiological recording of voltage-dependent currents. 6, 8 Live cells stained with FM1-43 were sorted by fluorescenceactivating cell sorting (FACS) (Figure 5a and b). Gene expression analysis revealed that the sorted cells expressed genes specific for hair cell mechanotransduction, including TMC1/2, 37-40 TMHS, 41 and TMIE Figures S5a and  b) . This may indicate that these clones have been genetically corrected. Furthermore, Sanger sequencing results revealed that the mutation at the MYO15A c.4642G4A locus of these 13 clones had been corrected (sequencing results also revealed a double-peak at the PAM synonymous mutation site in clones obtained by donor plasmid nucleofection) as shown in Supplementary Figure S5c . Off-target detection revealed that there were no double peaks adjacent to the top 12 suspected off-target sites in the 13 iPSC clones (Supplementary Figure S6a) . In other words, no off-targeting was found. In addition, several InDel mutations in iPSC clones, which had not been corrected by homology directed repair (HDR), but targeted by the CRISPR/Cas9 plasmid, were also detected (Supplementary Figure S6b) .
Subsequently, the expression of pluripotent marker genes and proteins in positive iPSC clones with the genotype of MYO15A
Correction/ − ( MC/ − iPSC) was examined. MC/ − iPSCs expressed marker proteins characteristic of hiPSC, including AP, OCT4, SOX2, NANOG, SSEA4, TRA-1-60, and TRA-1-81 (Figure 2a and b) , as well as iPSC endogenous marker genes, such as OCT4, SOX2, and NANOG. All exogenous transgenes were silenced in MC / − iPSCs (Supplementary Figure S2a) .
MC/ − iPSCs also formed EBs and teratomas and had the potential to form cells of the three germ layers in vitro and in vivo (Figure 2c and d) . Karyotype assays of the MC/ − iPSCs showed that the cells displayed a normal karyotype of 46XY (Supplementary Figure S2b) . These results showed that the mutation at the MYO15A c.4642G4A locus in M − / − iPSCs had been corrected successfully and that a new iPSC line with a genotype of MYO15A Correction/ − ( MC/− iPSCs) had been generated. To understand the effects of the genetic correction of MYO15A mutations on the morphology and function of the derived hair cell-like cells, we induced the differentiation of the MC/ − iPSCs into otic progenitors and further into inner ear hair cell-like cells. After the induction of the differentiation of MC/ − iPSCs into otic progenitors for 12 days, the expression of the early otic markers, including PAX2, PAX8, SOX2, and NES, was examined by immunocytochemistry (Figure 3a and  c) . Gene expression analysis also revealed that the induced cells expressed early otic marker genes. These included PAX2, PAX8, GATA3, EYA1, SIX1, and DLX5 (Figure 3d) . No difference in the expression patterns for the early otic markers was observed between the otic progenitors from M+/+ iPSCs, M+/− iPSCs, and MC/ − iPSCs (Figure 3e ). Furthermore, the differentiation of otic epithelial progenitors from the MC/ − iPSCs into inner ear hair cells was induced. After 21 days of induction, immunocytochemistry and western blot assays revealed that the hair cell-like cells induced from MC/ − iPSCs expressed hair cell markers, including BRN3C, ATOH1, MYO7A, and ESPN (Figure 4a and d) . Gene expression analysis indicated that the induced cells expressed hair cell marker genes, including BRN3C, ATOH1, MYO7A, and ESPN (Figure 4f ). In addition, MYO15A was also detected, as shown in Figure 4f Figure S5d) . This gave further evidence of the success of the genetic correction.
Discussion iPSC technology enables the development of study models for many diseases by facilitating the generation of patient-specific stem cells. 44 In this study, deafness patient-specific iPSCs were generated from a Chinese boy carrying MYO15A c.4642G4A and c.8374G4A compound heterozygous mutations. These were induced into inner ear hair cell-like cells to examine the effects of the MYO15A mutations on the morphology and function of the derived hair cell-like cells. Our results showed that the MYO15A mutations had no effect on the totipotency of iPSCs. However, the morphology and function of hair cell-like cells induced from the M+/+ iPSCs, M+/ − iPSCs, and M − / − iPSCs were found to be different. Some of the cells induced from the M − / − iPSCs aggregated together and formed syncytia, whereas no syncytia were found in the cells induced from the M+/+ iPSCs or M+/ − iPSCs. To our knowledge, no previous studies have yet reported relationships between human MYO15A mutations and syncytia formation. The formation of syncytia may occur through cell fusion or mitotic disorders. 45, 46 In this study, some of the induced cells with human MYO15A mutations formed syncytia accompanied with F-actin disorganization. This requires further investigation as to whether syncytia formation of some induced cells can be attributed to a mitotic disorder resulted from a MYO15A mutation-mediated F-actin disorder.
Myo15a localizes to the inner ear sensory cell stereocilia in mouse cochlea and is essential for the formation of a staircase pattern of hair bundles. 18 In Myo15a sh2 mouse cochlea, the hair cell stereocilia are much shorter compared with those of the wild type. 47 In our study, SEM detection showed that although the surface of the cells induced from the iPSCs. Actin is fundamental for the structure of stereocilia. 48 Previous studies in mice also indicated that Whrn and Eps8 have vital roles in actin regulation in hair cells. 16, 49, 50 Myo15a interacts with Whrn and Eps8, and transports these cargos to the tips of the stereocilia. 16, 51 This process is considered as the basis of the elongation of stereocilia in hair cells. Based on the phenomenon of F-actin disorganization in the cells induced from M − / − iPSCs, we deduce that human MYO15A mutations may result in F-actin disorganization and consequently cause abnormally shortened stereocilia in the induced hair cell-like cells. Our study confirmed that MYO15A is essential for the elongation of inner ear hair cell stereocilia during the differentiation of otic epithelial progenitors into inner ear hair cells.
CRISPR/Cas9 technology allows us to edit the genome precisely with low probability of changing the cellular genetic background. 52 It has been reported that the genetic correction of homozygous mutations does indeed reverse the disease phenotype caused by the homozygous mutation. 53, 54 In patients suffering from hereditary diseases, however, homozygous mutations are in the minority, and compound heterozygous mutations are dominant. Although most individuals carry a single allele mutation, no homologous disease symptoms are present. For example, the father of the M − / − deaf patient had a genotype of M+/ − with normal hearing. Therefore, we hypothesized that the genetic correction of one locus in the compound heterozygous mutations should be sufficient for the functional reconstruction of M − / − iPSCs. Therefore, we genetically corrected the MYO15A c.4642G4A mutation in the M − / − iPSC line using CRISPR/Cas9 technology and generated a new iPSC line ( MC/ − iPSC line). The differentiation of MC/ − iPSCs into hair cell-like cells was then induced. In this case, the results showed no syncytia formation during differentiation. After 21 days of induction, the immunostaining and electrophysiological recordings showed significant differences in the electrophysiological properties between cells induced from MC/ − iPSCs and M − / − iPSCs. SEM observation showed that the length of the stereocilia on the surface of cells induced from MC/− iPSCs was identical to that of cells induced from M+/+ iPSCs or M+/ − iPSCs and significantly longer than that of stereocilia on cells induced from M − / − iPSCs. These results indicated that the genetic correction of one locus in the compound heterozygous mutation loci was sufficient for the reversal of the abnormal phenotype (F-actin disorganization, abnormally short stereocilia as well as syncytia formation) and dysfunction (current density) caused by the MYO15A mutations.
In summary, our results showed that the rescue of F-actin organization, stereocilia length, and electrophysiological parameters in hair cell-like cells derived from MC/ − iPSCs was indeed due to the genetic correction of the MYO15A c.4642G4A mutation in the M − / − iPSCs. Thus, our data indicate that it is feasible to generate iPSCs from human patient tissues to induce the differentiation of these iPSCs into hair cell-like cells and to genetically correct such deafness mutations in human iPSCs. These findings provide a step toward the development of therapeutic interventions for similar cases of hereditary deafness.
Material and Methods
Subjects and clinical evaluations. This study was approved by the Institutional Review Boards of Zhejiang University, Hangzhou, China, and the Ethical Committee of the People's Hospital of Wenling, Zhejiang, China. Written informed consent was obtained from adult subjects and the parents of minor subjects. The gDNA samples were subjected to a deafness genetic screen using a custom-made capture kit for 69 deafness genes and mitochondrial DNA (Roche NimbleGen, Inc.).
Generation of iPSCs.
Human epidermic tissues were obtained from donors' arms with a 6-mm skin punch (Vetlab Supply, Palmetto Bay, FL, USA). Primary fibroblasts were isolated and cultured as previously described. 55 Reprogramming was adapted from Takahashi et al. 28 Small molecule compounds were added into the iPSC medium to enhance the induction efficiency. Human iPSCs were cultured on mitomycin C-inactivated MEFs.
Totipotency of human iPSCs. To characterise the totipotency of induced iPSCs, EB formation from iPSCs was performed as previously described. 53 For analysis of in vivo differentiation of iPSCs, teratoma formation was performed as previously described. 56 Animal care and usage was approved by the Institutional IACUC Committee and the Laboratory Animal Welfare Ethical Committee of Zhejiang University.
Genetic correction of iPSCs carrying the MYO15A c.4642G4A mutation. The genetic correction of iPSCs with the MYO15A c.4642G4A mutation was performed using CRISPR-Cas9 technology (Supplementary Figure S2) . For FACS, we added a selectable marker, a CMV-maxGFP-polyA cassette amplified from pmaxGFP (Lonza, Shanghai, China), and cloned it into the plasmid pX330 to construct the plasmid pX330-maxGFP. We constructed a 130-bp ssODN and a donor plasmid pUC19-MYO15A synonymous for HDR templates. Nucleofection technology was used to transfect the Cas9 plasmid and HDR templates. Positive clones were selected by FACS sorting, restriction fragment length polymorphism analysis and Sanger sequencing.
Induction of iPSCs toward inner ear hair cells. iPSCs were induced toward inner ear hair cells using a slightly modified protocol. 8 After 12 days of differentiation, otic epithelial progenitors (OEPs) were isolated and collected for hair cell induction. To induce differentiation of OEPs into hair cells, the cells collected were transferred and seeded at a density of 1000 cell/cm 2 onto a Matrigel-coated plate that had been pre-seeded with mitotically inactivated embryonic day 18 CUSCs. 6 Gene expression analysis. Total RNA was extracted from cells using TRIzol reagent (Life Technologies, Shanghai, China) including treatment with RNase-Free DNase I (Sigma-Aldrich, Shanghai, China). cDNA synthesis was performed with the M-MLV Reverse Transcriptase Kit (Fermentas, Shanghai, China). Total gDNA was isolated with QuickExtract DNA Extraction Solution (Epicentre Biotechnologies, Beijing, China). The primers and PCR conditions are listed in Supplementary  Table S4. SEM. Cells were fixed in 2.5% glutaraldehyde (Sigma-Aldrich) in PBS at 4°C overnight. After three PBS washes for 15 min each, cells were post-fixed in 1% OsO 4 in PBS for 2 h and then washed three times for 15 min. Cells were then dehydrated with a graded ethanol series for 15 min each. After being dehydrated two times in 100% ethanol, samples were transferred into isoamyl acetate for 1 h, dehydrated with liquid CO 2 in a Hitachi Model HCP-2 critical point dryer, coated with gold-palladium in a Hitachi Model E-1010 ion sputter for 5 min, and observed under a Hitachi SU8010 SEM.
Electrophysiological recordings. For cells that had been differentiated for 21 days, a whole-cell patch-clamp technique was used to measure the membrane currents with EPC10 Patch-Clamp Amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). A FM1-43FX (Life Technologies) working staining solution of 5 μg/ml was prepared in PBS without Ca 2+ and Mg
2+
. Cells that took up FM1-43FX exhibited green fluorescence and were sorted for electrophysiological recordings. The data were acquired using the PatchMaster software and a Digidata analog-todigital converter (Molecular Devices, Sunnyvale, CA, USA) and analyzed using the Clampfit and Origin (OriginLab, Guangzhou, China) software.
Statistics. Experimental results are expressed as ± the S.E.M. unless otherwise stated. Statistical analysis of one-way variance (ANOVA) was performed using Origin software. Statistical significance was considered as Po0. 05 .
Fuller details of material and methods are presented in Supplementary material and methods.
